A comparison of R-CHOP and R-DA-EPOCH as a first-line regimen treatment of diffuse large B cell lymphoma with non-GCB subtypes: a retrospective study.
- Author:
Zi Yan HE
1
;
Wen Juan YU
2
;
Shan Shan SUO
2
;
Jing Han WANG
2
;
Hai Tao MENG
2
;
Wen Yuan MAI
2
;
Ju Ying WEI
2
;
Min YANG
2
;
Li Ping MAO
2
;
Jie JIN
2
Author Information
- Publication Type:Journal Article
- MeSH: Antineoplastic Combined Chemotherapy Protocols/therapeutic use*; Cyclophosphamide/therapeutic use*; Doxorubicin/therapeutic use*; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse/pathology*; Prednisone/therapeutic use*; Prognosis; Retrospective Studies; Rituximab/therapeutic use*; Vincristine/therapeutic use*
- From: Chinese Journal of Hematology 2022;43(4):346-348
- CountryChina
- Language:Chinese
